Lung Therapeutics, Inc.

Track

Insider profile

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return 16% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Lung Therapeutics, Inc.'s trades of TFF Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
327.64
Quantity 33,059 +21.0%
Value US$2,628,883
Transaction date
Sale
Price
15.37
Quantity 19,218 +26.4%
Value US$1,217,045
Transaction date
Sale
Price
280.32
Quantity 32,797 +37.2%
Value US$1,096,127
Transaction date
Sale
Price
13.85
Quantity 500,000 -12.5%
Value US$6,925,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-03-30 2021-03-26
S Sale
33,059 +21.0%
327.64
US$2,628,883 		33,059 +21.0% 327.64 US$2,628,883
2020-12-08 2020-12-04
S Sale
19,218 +26.4%
15.37
US$1,217,045 		19,218 +26.4% 15.37 US$1,217,045
2020-12-08 2020-12-04
S Sale
32,797 +37.2%
280.32
US$1,096,127 		32,797 +37.2% 280.32 US$1,096,127
2020-12-08 2020-12-04
S Sale
500,000 -12.5%
13.85
US$6,925,000 		500,000 -12.5% 13.85 US$6,925,000